Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Zydus Lifesciences Ltd.
NSE: ZYDUSLIFE
|
BSE: 532321
|
ISIN: INE010B01027
|
Industry: Pharmaceuticals
US FDA Approval
|
Falling Comet
883.1500
14.30
(
1.65
%)
NSE
Apr 15, 2025
15:31 PM
33.31% Fall from 52W High
Volume:
1.6M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Zydus Lifesciences Ltd.
29 May 2024
US FDA Approval
883.15
1.65%
ZYDUS LIFESCIENCES LIMITED
Accumulate:
Zydus Lifesciences Ltd.
by
Geojit BNP Paribas
Target: 1196 | Target met
Recommendation
Target
Geojit BNP Paribas
Zydus Lifesciences Ltd. is trading below all available SMAs
More from Zydus Lifesciences Ltd.
Recommended
Chart of the week: Capex surge puts order books of railway companies on the fast track
The Baseline |
15 Apr 2025, 04:53PM
Market closes higher, Capacite Infra wins a Rs 220 crore order from TenX Realty
Trendlyne Marketwatch |
15 Apr 2025, 03:57PM
Earnings Call Transcript - Cadila Healthcare
|
14 Feb 2020, 01:51PM